Property | Value |
?:abstract
|
-
Patients with acute Coronavirus-19 (COVID-19) respiratory infections are associated with concomitant thromboembolic complications and a hypercoagulable state. Although these mechanisms are not completely understood, unique alterations in serum markers for hemostasis and thrombosis have been detected. A high index of suspicion is required by vascular surgeons in patients presenting with this novel virus. We present the case of a 51 year old male with acute COVID-19 pneumonia who developed Phlegmasia Cerulea Dolens despite chronic warfarin therapy and a supratherapeutic International Normalized Ratio (INR).
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
-
10.1016/j.jvscit.2020.10.002
|
?:journal
|
-
J_Vasc_Surg_Cases_Innov_Tech
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/709cbef899046b0731ddd0a16e71dbabb9643b47.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7571495.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Phlegmasia Cerulea Dolens Associated with Acute COVID-19 Pneumonia Despite Supratherapeutic Warfarin Anticoagulation
|
?:type
|
|
?:year
|
|